Explore the urgent public health issue of carbapenem-resistant Acinetobacter spp. infections in this 44-minute video featuring expert discussions with Dr. Yohei Doi and Dr. Joseph Patrick Hornak. Delve into the scarcity of antibiotic options, potential new drugs on the horizon, and current treatment strategies. Learn about betalactamases, emergency use protocols, and the silent epidemic of these infections. Gain insights on empirical approaches, dose considerations, toxicities, and management of other related infections. Understand the background, objectives, and latest developments in treating this challenging bacterial threat through real-world case studies and expert analysis.
Overview
Syllabus
Intro
Objectives
Background
Why now
Case
Initial regimens
Dose and toxicities
What happened to the patient
Betalactamases
What happened in the interim
Emergency use protocol
The silent epidemic
New drugs
Empirical approach
Other infections
Conclusion
Taught by
American Society for Microbiology
